Skip to main content
Skip to section navigation
Skip to footer
Home
About
Overview
Management Team
Board of Directors
Advisory Board
Pipeline
Overview
XRx-026 for Gout
XRx-008 for Autosomal Dominant Polycystic Kidney Disease
XRx-101 for Coronavirus/COVID-19
225 for Type 2 Diabetic Nephropathy
Publications
Technology
News & Media
Press Releases
Events
In the News
Investors
Overview
News & Events
Presentations
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR+
Governance
Contact
Press Releases
News & Media
News & Media
Press Releases
Events
In the News
Year
All Years
2025
2024
2023
2022
2021
2020
2019
2018
Sep 02, 2021 2:26pm EDT
XORTX Therapeutics Reports Special Meeting Results
Sep 01, 2021 7:00am EDT
XORTX Announces Grant of European Patent
Aug 31, 2021 9:11am EDT
XORTX Announces New Clinical Advisory Board Member
Aug 13, 2021 5:00pm EDT
XORTX Therapeutics Calls Special Meeting of Shareholders
Jul 14, 2021 7:00am EDT
XORTX Therapeutics Strengthens Executive Team
Jun 30, 2021 7:00am EDT
Dr. Stephen Haworth Joins XORTX Management Team
Jun 17, 2021 7:00am EDT
XORTX Welcomes Jaqueline Le Saux to Board of Directors
May 13, 2021 7:00am EDT
XORTX Welcomes New Member to Board of Directors
Apr 06, 2021 7:00am EDT
XORTX Announces Notice to Grant European Patent
Mar 16, 2021 7:00am EDT
XORTX to Present at “Zoom With LD MICRO”
arrow_back
1…
7
8
9
10
11
12
13
14
15
16
…18
arrow_forward
rss_feed
News RSS